CalciMedica Management
Management criteria checks 2/4
CalciMedica's CEO is A. Leheny, appointed in Sep 2019, has a tenure of 5.17 years. total yearly compensation is $1.10M, comprised of 28.9% salary and 71.1% bonuses, including company stock and options. directly owns 0.98% of the company’s shares, worth $447.62K. The average tenure of the management team and the board of directors is 4.5 years and 4.5 years respectively.
Key information
A. Leheny
Chief executive officer
US$1.1m
Total compensation
| CEO salary percentage | 28.9% |
| CEO tenure | 5.2yrs |
| CEO ownership | 1.0% |
| Management average tenure | 4.5yrs |
| Board average tenure | 4.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$14m |
| Jun 30 2024 | n/a | n/a | -US$13m |
| Mar 31 2024 | n/a | n/a | -US$15m |
| Dec 31 2023 | US$1m | US$319k | -US$34m |
Compensation vs Market: A.'s total compensation ($USD1.10M) is above average for companies of similar size in the US market ($USD646.00K).
Compensation vs Earnings: Insufficient data to compare A.'s compensation with company performance.
CEO
A. Leheny (61 yo)
5.2yrs
Tenure
US$1,101,478
Compensation
Dr. A. Rachel Leheny, Ph D., is Chief Executive Officer and Director of CalciMedica Subsidiary, Inc. She is Director of Graybug Vision, Inc. from February 5, 2023. She serves as Chief Executive Officer and...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 5.2yrs | US$1.10m | 0.98% $ 447.6k | |
| Chief Business Officer & Vice Chairman of the Board | 4.5yrs | US$894.15k | 1.42% $ 650.1k | |
| Co-Founder & Chief Scientific Officer | 18.8yrs | US$770.99k | 0.089% $ 40.5k | |
| President & COO | 7.4yrs | no data | 0.087% $ 39.9k | |
| Co-Founder and Scientific Advisor | no data | no data | no data | |
| Co-Founder and Scientific Advisor | no data | no data | no data | |
| Co-Founder and Scientific Advisor | no data | no data | no data | |
| Chief Financial Officer | less than a year | no data | no data | |
| General Counsel | 3.8yrs | no data | no data | |
| Chief Medical Officer | 8yrs | no data | 0.34% $ 156.1k | |
| Chief Regulatory Officer | 1.8yrs | no data | no data | |
| Senior Vice President of Clinical Development | 1.8yrs | no data | no data |
4.5yrs
Average Tenure
61yo
Average Age
Experienced Management: CALC's management team is considered experienced (4.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 5.2yrs | US$1.10m | 0.98% $ 447.6k | |
| Chief Business Officer & Vice Chairman of the Board | 4.5yrs | US$894.15k | 1.42% $ 650.1k | |
| Independent Director | 4.5yrs | US$86.01k | 0.30% $ 135.3k | |
| Independent Director | 3.1yrs | US$97.34k | 0% $ 0 | |
| Independent Chairman of the Board | 4.4yrs | US$115.26k | 3.1% $ 1.4m | |
| Independent Director | no data | US$122.53k | 0.027% $ 12.5k | |
| Director | 5.8yrs | US$2.10m | 0.67% $ 307.8k |
4.5yrs
Average Tenure
61yo
Average Age
Experienced Board: CALC's board of directors are considered experienced (4.5 years average tenure).